Serum vascular endothelial growth factor-D as a diagnostic and therapeutic biomarker for lymphangioleiomyomatosis

BACKGROUND: In lymphangioleiomyomatosis (LAM), tuberous sclerosis gene mutations activate the mechanistic target of the rapamycin pathway, resulting in vascular endothelial growth factor-D (VEGF-D) overproduction. While the utility of serum VEGF-D testing for the diagnosis of LAM is outlined in ATS/...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Hirose, Masaki, Matsumuro, Akiko, Arai, Toru, Sugimoto, Chikatoshi, Akira, Masanori, Kitaichi, Masanori, Young, Lisa R., McCormack, Francis X., Inoue, Yoshikazu
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6395035/
https://ncbi.nlm.nih.gov/pubmed/30818375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0212776
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados